Affiliation:
1. E.I. Chazov National Medical Research Center of Cardiology
2. E.I. Chazov National Medical Research Center of Cardiology; Pirogov Russian National Research Medical University
Abstract
Aim. To assess frequency and severity of sleep breathing disorders in patients with uncontrolled hypertension among patients referred to a sleep laboratory.Materials and methods. 113 patients aged 18-80 years with arterial hypertension (AH) were included. All patients underwent sleep cardiorespiratory monitoring, general clinical and laboratory diagnostics. Uncontrolled hypertension was defined as systolic blood pressure (BP) >140 mm Hg, or diastolic BP >90 mm Hg. in case of permanent antihypertensive therapy (AHT) taking.Results. Among all patients with uncontrolled hypertension (Group 1; n=42, 37,2%), 95,2% had obstructive sleep apnea syndrome (OSA). Compared with the controlled hypertension group (Group 2), AHI and ODI were higher in Group 1 (AHI 28,0 events/hour [14,8; 51,8] vs. 17,5 events/hour [8,7; 39,0], p=0,03; ODI 25,3 events/hour [14,4; 50,6] versus 17,1 events/hour [8,5; 37,0], p=0,04). In addition, these parameters turned out to be markers of uncontrolled hypertension (AHI >19,9 events/hour, AUC=0,62, p=0,03; OR 3,23, 95%; CI 1,7-6,1, p=0,00; ODI >19,5 events/hour, AUC=0,62, p=0,03; OR 3,07, 95% CI 1,7-5,7, p=0,01). The level of systolic BP >146 mm Hg. turned out to be a marker of the moderate or severe OSA (AUC=0,66, p=0,00; OR 4,45, 95% CI 1,811,2, p=0,00).Conclusion. High incidence of moderate or severe OSA in patients with uncontrolled hypertension emphasizes the importance of sleep breathing disorders examining in these patients. Timely diagnostics and treatment of OSA probably will allow to provide better BP levels control and thus will lead to reducing of cardiovascular risk.
Reference70 articles.
1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American Society of Hypertension. 2018;12(8):579.e571-579.e573.
2. Kingue S, Ngoe CN, Menanga AP, Jingi AM, Noubiap JJN, Fesuh B, et al. Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population-based cross-sectional study. J Clin Hypertens. 2015;17(10):819–24. https://doi.org/10.1111/jch.12604
3. Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam CK, et al. Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ Open. 2012;2(4):e001217. https://doi.org/10.1136/bmjopen-2012-001217
4. Iloh GU, Ofoedu JN, Njoku PU, Amadi AN, Godswill-Uko EU. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in eastern Nigeria. Afr J Prim Health Care Fam Med. 2013;5(1):446. http://dx.doi.org/10.1186/s12872-020-01741-5
5. Elder K, Ramamonjiarivelo Z, Wiltshire J, Piper C, Horn WS, Gilbert KL, et al. Trust, medication adherence, and hypertension control in southern African American men. Am J Public Health. 2012;102(12):2242–5. https://doi.org/10.2105/ajph.2012.300777